REGISTERED NUMBER: 07049170 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

INTERPHARM INVESTMENTS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

D Casadei Massari

F M Patrocollo

P Ranson

REGISTERED OFFICE:

Cole Street Studios

6-8 Cole Street

London

SE1 4YH

REGISTERED NUMBER:

07049170 (England and Wales)

ACCOUNTANTS:

EZ ACCOUNTING

Chartered Certified Accountants

Cole Street Studios

6-8 Cole Street

London

SE1 4YH

TOTAL ASSETS LESS CURRENT LIABILITIES

-

-

CREDITORS

Amounts falling due after more than one year

4

29,431

29,431

NET LIABILITIES

(29,431

)

(29,431

)

CAPITAL AND RESERVES

Called up share capital

590

590

Share premium

494,828

494,828

Retained earnings

(524,849

)

(524,849

)

SHAREHOLDERS' FUNDS

(29,431

)

(29,431

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 December 2025 and were signed on its behalf by:

D Casadei Massari - Director

1.	STATUTORY INFORMATION

Interpharm Investments Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern

The company is not a going concern and it was kept 'dormant' by the directors in the current year.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Other creditors

29,431

29,431

5.	RELATED PARTY DISCLOSURES

At the year end the company owed £29,431 (2021: £29,431) to a director of the company. This loan is provided to the company interest free.